Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Rutkowski

Showing results (181-190 of 491) with videos related to

Pageof 50
Sort By:
Scientific Reports|February 12, 2025
Systemic inflammation index is a predictive and prognostic factor in patients with liposarcoma or leiomyosarcoma treated with trabectedinPawel Sobczuk, Paulina Filipowicz, Lukasz Lamparski, et al.
Journal of Clinical Medicine|June 2, 2021
Feasibility and Long-Term Efficacy of PEComa Treatment-20 Years of ExperienceAleksandra Sobiborowicz, Tomasz Świtaj, Paweł Teterycz, et al.
Annals of Surgical Oncology|January 18, 2006
Surgery combined with intraoperative brachytherapy in the treatment of retroperitoneal sarcomasWirginiusz Dziewirski, Piotr Rutkowski, Zbigniew I Nowecki, et al.
Contemporary Oncology (Poznan, Poland)|February 9, 2018
The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)Piotr Rutkowski, Beata Jagielska, Jolanta Andrzejuk, et al.
Oncology Letters|June 25, 2014
Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcomePiotr Rutkowski, Aleksandra Gos, Monika Jurkowska, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 17, 2021
What is the best front-line approach in patients with desmoid fibromatosis? - A retrospective analysis from a reference centerPaweł Sobczuk, Izabela M Agnieszczak, Wiktoria Grycuk, et al.
Journal of Contemporary Brachytherapy|December 30, 2016
Surgery combined with brachytherapy in patients with retroperitoneal sarcomasWirginiusz Dziewirski, Piotr Rutkowski, Zbigniew I Nowecki, et al.
Contemporary Oncology (Poznan, Poland)|March 6, 2014
Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysisKatarzyna Wiater, Tomasz Switaj, Jacek Mackiewicz, et al.
Oncology Research|July 1, 2024
Inflammatory myofibroblastic tumor from molecular diagnostics to current treatmentPaulina Chmiel, Aleksandra SłOWIKOWSKA, Łukasz Banaszek, et al.
Cancer|April 2, 2011
Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resectionPiotr Rutkowski, Agnieszka Wozniak, Maria Dębiec-Rychter, et al.
Pageof 50

Showing results (181-190 of 491) with videos related to

Sort By:
Pageof 50
Scientific Reports|February 12, 2025
Systemic inflammation index is a predictive and prognostic factor in patients with liposarcoma or leiomyosarcoma treated with trabectedinPawel Sobczuk, Paulina Filipowicz, Lukasz Lamparski, et al.
Journal of Clinical Medicine|June 2, 2021
Feasibility and Long-Term Efficacy of PEComa Treatment-20 Years of ExperienceAleksandra Sobiborowicz, Tomasz Świtaj, Paweł Teterycz, et al.
Annals of Surgical Oncology|January 18, 2006
Surgery combined with intraoperative brachytherapy in the treatment of retroperitoneal sarcomasWirginiusz Dziewirski, Piotr Rutkowski, Zbigniew I Nowecki, et al.
Contemporary Oncology (Poznan, Poland)|February 9, 2018
The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)Piotr Rutkowski, Beata Jagielska, Jolanta Andrzejuk, et al.
Oncology Letters|June 25, 2014
Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcomePiotr Rutkowski, Aleksandra Gos, Monika Jurkowska, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 17, 2021
What is the best front-line approach in patients with desmoid fibromatosis? - A retrospective analysis from a reference centerPaweł Sobczuk, Izabela M Agnieszczak, Wiktoria Grycuk, et al.
Journal of Contemporary Brachytherapy|December 30, 2016
Surgery combined with brachytherapy in patients with retroperitoneal sarcomasWirginiusz Dziewirski, Piotr Rutkowski, Zbigniew I Nowecki, et al.
Contemporary Oncology (Poznan, Poland)|March 6, 2014
Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysisKatarzyna Wiater, Tomasz Switaj, Jacek Mackiewicz, et al.
Oncology Research|July 1, 2024
Inflammatory myofibroblastic tumor from molecular diagnostics to current treatmentPaulina Chmiel, Aleksandra SłOWIKOWSKA, Łukasz Banaszek, et al.
Cancer|April 2, 2011
Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resectionPiotr Rutkowski, Agnieszka Wozniak, Maria Dębiec-Rychter, et al.
Pageof 50